Chinook: Versant reimagines its Chinook success with newest startup launch
Borealis Biosciences launches with money from Novartis, which last year bought the biotech's predecessor for a pair of drugs that treat a rare kidney disorder.
Read full article »
Chinook is a Washington-based clinical-stage biopharmaceutical company that researches and develops precision drugs for the treatment of chronic kidney disease.
Read more